NexPoint Real Estate Finance, Inc.
NREF
Sync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, NexPoint Real Estate Finance, Inc. shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
7-Year Financial Trajectory
Annualinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
319.6%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
70.0%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
172.7%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-96.3%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
181.7%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — |
| Net Income Growth YoY (%) |
242.4%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
91.9%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
31.8%
Excellent
→
Excellent
Stable
Year-over-year change in net income |
-83.0%
Weak
Weak
Year-over-year change in net income |
144.3%
Excellent
Excellent
Year-over-year change in net income |
— | — |
| FCF Growth YoY (%) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR 3Y (%) |
169.0%
Excellent
↑
Excellent
Improving
Compound annual EPS growth over 3 years |
-44.6%
Weak
Weak
Compound annual EPS growth over 3 years |
-34.4%
Weak
Weak
Compound annual EPS growth over 3 years |
— | — | — | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| FCF Margin (%) (%) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF / Net Income (x) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Capital (%) (%) |
2.3%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
0.7%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
0.3%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
0.2%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
1.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
0.6%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
| Return on Common Equity (%) (%) | — | — | — | — | — |
26.6%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+233%)
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — | — | — | — | — |
8.10x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+710%)
|
— |
| Interest Coverage (x) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Debt (USD) | $740.09M | $795.43M | $1.26B | $1.33B | $-26.46M | $1.01B | — |
| Debt / EBITDA (x) N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Depreciation Expense (USD) | $2.94M | $5.61M | $2.46M | $2.90M | $0.00 | — | — |
| Net Income, GAAP (USD) | $123.14M | $35.96M | $18.74M | $14.21M | $83.47M | $34.17M | — |
| Operating Cash Flow (USD) | $22.92M | $29.28M | $31.56M | $65.80M | $49.30M | $32.90M | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ | FY 2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| FFO (approx.) (USD) | $126.09M | $41.58M | $21.20M | $17.11M | $83.47M | — | — |
| FFO per Share (approx.) (USD) | $7.13 | $2.39 | $1.23 | $1.16 | $12.65 | — | — |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare NREF with peers
Stack NREF against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 7 years · 26 quarters